http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0995439-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| filingDate | 1999-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71af454d807c01151118c681e6ade4d8 |
| publicationDate | 2000-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0995439-A1 |
| titleOfInvention | Use of indazole derivatives in the manufacture of a medicament for treating congestive heart failure |
| abstract | The present invention relates to methods for treating congestive heart failurenin a mammal by administering a congestive heart failure treating amount of ancompound which inhibits phosphodiesterase type IV and the production of tumornnecrosis factor, such as, for example, a substituted indazol derivative, e.g., of thenformulan nor a pharmaceutically acceptable salt thereof, wherein R, R 1 and R 2 are as definednherein. The invention further relates to pharmaceutical compositions for thentreatment of congestive heart failure comprising a congestive heart failure treatingnamount of a compound which inhibits phosphodiesterase type IV and the productionnof tumor necrosis factor, such as, for example, a substituted indazol derivative, e.g.,nof formula (I) herein, or a pharmaceutically acceptable salt thereof, and anpharmaceutically acceptable vehicle, diluent or carrier. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7601847-B2 |
| priorityDate | 1998-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.